CLINICAL_TRIALS ClinicalTrials.gov record update

Chimeric Antigen Receptor-Modified pNK Cells for CD7 Positive Relapsed or Refractory Leukemia and Lymphoma

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT02742727
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:36:21.301419+00:00
Published At: 2016-12-06T00:00:00+00:00
Record Updated At: 2016-12-06
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Acute Myeloid Leukemia", "Precursor T-Cell Lymphoblastic Leukemia-Lymphoma", "T-cell Prolymphocytic Leukemia", "T-cell Large Granular Lymphocytic Leukemia", "Peripheral T-cell Lymphoma, NOS", "Angioimmunoblastic T-cell Lymphoma", "Extranodal NK/T-cell Lymphoma, Nasal Type", "Enteropathy-type Intestinal T-cell Lymphoma", "Hepatosplenic T-cell Lymphoma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2016-12-06"
protocolSection.identificationModule.nctId: "NCT02742727"
protocolSection.identificationModule.officialTitle: "Chimeric Antigen Receptor-Modified pNK Cells for CD7 Positive Relapsed or Refractory Leukemia and Lymphoma"
protocolSection.statusModule.overallStatus: "UNKNOWN"
protocolSection.designModule.phases: ["PHASE1", "PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.